TY - JOUR
T1 - Brca genes and related cancers
T2 - A meta-analysis from epidemiological cohort studies
AU - Lee, Yen Chien
AU - Lee, Yen Ling
AU - Li, Chung Yi
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/9
Y1 - 2021/9
N2 - Background and Objectives: BRCA1 and BRCA2 are genes located in different chromosomes that are disproportionately associated with hereditary breast and ovarian cancer syndrome. Their association with other cancers remains to be explored. Materials and Methods: We systematically re-viewed cohort studies to explore the association of BRCA 1 and BRCA2 with various cancers except lung cancer. We searched PubMed, Medline (EBSCOhost) and relevant articles published up to 10 May 2021. The odds ratio, standardised morbidity rate and cancer-specific standardised incidence ratio were pooled together as relative risk (RR) estimates. Results: Twelve studies were included for anal-ysis. BRCA mutation increased pancreatic and uterine cancers by around 3–5-and 1.5-fold, respectively. BRCA mutation did not increase brain cancer; colorectal cancer; prostate, bladder and kidney cancer; cervical cancer; or malignant melanoma. BRCA2 increased gastric cancer with RR = 2.15 (1.98–2.33). Conclusion: The meta-analysis results can provide clinicians and relevant families with information regarding increased specific cancer risk in BRCA1 and BRCA2 mutation carriers.
AB - Background and Objectives: BRCA1 and BRCA2 are genes located in different chromosomes that are disproportionately associated with hereditary breast and ovarian cancer syndrome. Their association with other cancers remains to be explored. Materials and Methods: We systematically re-viewed cohort studies to explore the association of BRCA 1 and BRCA2 with various cancers except lung cancer. We searched PubMed, Medline (EBSCOhost) and relevant articles published up to 10 May 2021. The odds ratio, standardised morbidity rate and cancer-specific standardised incidence ratio were pooled together as relative risk (RR) estimates. Results: Twelve studies were included for anal-ysis. BRCA mutation increased pancreatic and uterine cancers by around 3–5-and 1.5-fold, respectively. BRCA mutation did not increase brain cancer; colorectal cancer; prostate, bladder and kidney cancer; cervical cancer; or malignant melanoma. BRCA2 increased gastric cancer with RR = 2.15 (1.98–2.33). Conclusion: The meta-analysis results can provide clinicians and relevant families with information regarding increased specific cancer risk in BRCA1 and BRCA2 mutation carriers.
UR - https://www.scopus.com/pages/publications/85114418575
UR - https://www.scopus.com/pages/publications/85114418575#tab=citedBy
U2 - 10.3390/medicina57090905
DO - 10.3390/medicina57090905
M3 - Review article
C2 - 34577828
AN - SCOPUS:85114418575
SN - 1010-660X
VL - 57
JO - Medicina (Lithuania)
JF - Medicina (Lithuania)
IS - 9
M1 - 905
ER -